Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Cirrhosis | 9 | 2020 | 1931 | 0.500 |
Why?
|
Carcinoma, Hepatocellular | 5 | 2020 | 2299 | 0.240 |
Why?
|
Nephritis, Hereditary | 1 | 2023 | 78 | 0.210 |
Why?
|
Hepatic Stellate Cells | 2 | 2020 | 119 | 0.190 |
Why?
|
Catechin | 1 | 2020 | 69 | 0.170 |
Why?
|
Collagen Type I | 2 | 2013 | 616 | 0.160 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2020 | 190 | 0.160 |
Why?
|
Anticarcinogenic Agents | 1 | 2020 | 249 | 0.150 |
Why?
|
Quinazolines | 2 | 2015 | 1363 | 0.150 |
Why?
|
Hepatitis C, Chronic | 2 | 2016 | 1031 | 0.140 |
Why?
|
Gadolinium | 3 | 2017 | 959 | 0.140 |
Why?
|
Diethylnitrosamine | 4 | 2020 | 45 | 0.140 |
Why?
|
Liver Neoplasms | 4 | 2016 | 4319 | 0.130 |
Why?
|
Liver Cirrhosis, Experimental | 1 | 2015 | 29 | 0.120 |
Why?
|
Fibrosis | 2 | 2023 | 2042 | 0.120 |
Why?
|
Polysaccharides, Bacterial | 1 | 2017 | 574 | 0.120 |
Why?
|
Elasticity Imaging Techniques | 2 | 2016 | 388 | 0.120 |
Why?
|
Carbon Tetrachloride | 4 | 2017 | 72 | 0.120 |
Why?
|
Biomimetics | 1 | 2015 | 173 | 0.110 |
Why?
|
Lipase | 1 | 2016 | 324 | 0.110 |
Why?
|
Epidermal Growth Factor | 1 | 2016 | 695 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 6 | 2023 | 36290 | 0.100 |
Why?
|
Interleukins | 1 | 2016 | 785 | 0.090 |
Why?
|
Rats, Wistar | 4 | 2016 | 1850 | 0.090 |
Why?
|
Liver | 3 | 2017 | 7509 | 0.090 |
Why?
|
Disease Progression | 4 | 2016 | 13502 | 0.090 |
Why?
|
Cisplatin | 1 | 2015 | 1644 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 2 | 2015 | 5643 | 0.080 |
Why?
|
Disease Models, Animal | 9 | 2023 | 18137 | 0.080 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1613 | 0.080 |
Why?
|
Metformin | 1 | 2016 | 912 | 0.080 |
Why?
|
Rats | 7 | 2020 | 23711 | 0.070 |
Why?
|
Sirolimus | 1 | 2015 | 1547 | 0.070 |
Why?
|
Cell Culture Techniques | 1 | 2015 | 1664 | 0.070 |
Why?
|
Kidney | 1 | 2023 | 7064 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2016 | 2828 | 0.070 |
Why?
|
Molecular Imaging | 1 | 2012 | 818 | 0.060 |
Why?
|
Half-Life | 2 | 2017 | 652 | 0.060 |
Why?
|
Liver Transplantation | 1 | 2016 | 2325 | 0.060 |
Why?
|
Ligation | 2 | 2015 | 448 | 0.060 |
Why?
|
Bile Ducts | 2 | 2015 | 282 | 0.050 |
Why?
|
Stem Cells | 1 | 2016 | 3523 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13630 | 0.050 |
Why?
|
Random Allocation | 2 | 2016 | 2394 | 0.050 |
Why?
|
Biopsy, Needle | 2 | 2016 | 1630 | 0.050 |
Why?
|
Molecular Probes | 2 | 2013 | 313 | 0.050 |
Why?
|
Mice, Inbred Strains | 2 | 2014 | 1763 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5253 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2016 | 15789 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2016 | 7850 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9467 | 0.040 |
Why?
|
Tea | 1 | 2020 | 284 | 0.040 |
Why?
|
Animals | 10 | 2023 | 167963 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2015 | 6315 | 0.040 |
Why?
|
ROC Curve | 2 | 2015 | 3568 | 0.030 |
Why?
|
Mice | 6 | 2023 | 81208 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2017 | 2262 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15697 | 0.030 |
Why?
|
Precancerous Conditions | 1 | 2020 | 977 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2016 | 11071 | 0.030 |
Why?
|
Hydroxyproline | 1 | 2012 | 110 | 0.030 |
Why?
|
Interferons | 1 | 2016 | 705 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1617 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13262 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2192 | 0.020 |
Why?
|
Prognosis | 3 | 2016 | 29658 | 0.020 |
Why?
|
Male | 9 | 2020 | 359744 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2015 | 10446 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2015 | 18957 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2015 | 16939 | 0.020 |
Why?
|
Hepacivirus | 1 | 2016 | 1334 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3804 | 0.020 |
Why?
|
Reference Values | 1 | 2016 | 4925 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 1484 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5039 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2016 | 6238 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2016 | 4810 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15840 | 0.020 |
Why?
|
Hepatocytes | 1 | 2014 | 1229 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6068 | 0.020 |
Why?
|
Tissue Donors | 1 | 2016 | 2313 | 0.020 |
Why?
|
Graft Survival | 1 | 2016 | 3794 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 5797 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6544 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2016 | 3061 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10827 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12159 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7588 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8313 | 0.010 |
Why?
|
Graft Rejection | 1 | 2016 | 4426 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16546 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 12960 | 0.010 |
Why?
|
Contrast Media | 1 | 2012 | 5305 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39261 | 0.010 |
Why?
|
Humans | 5 | 2016 | 760621 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 41335 | 0.010 |
Why?
|
Middle Aged | 2 | 2016 | 220352 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 58741 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 65017 | 0.010 |
Why?
|
Risk Factors | 1 | 2016 | 74359 | 0.000 |
Why?
|
Female | 2 | 2016 | 391270 | 0.000 |
Why?
|
Adult | 1 | 2016 | 219994 | 0.000 |
Why?
|
Concepts
(102)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_